Rapid First- and Second-Line Drug Susceptibility Assay for Mycobacterium tuberculosis Isolates by Use of Quantitative PCR
Authors:
- 1 January 2011
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 49 (1) , 69-75
Abstract
The slow turnaround time for Mycobacterium tuberculosis drug susceptibility results is a barrier to care. We developed a rapid quantitative PCR (qPCR)-based phenotypic antimicrobial susceptibility test that utilizes amplification of the M. tuberculosis 16S rRNA gene after 3 days of incubation with antituberculosis drugs. To decrease background from killed organisms, we used propidium monoazide (PMA), a DNA-binding dye that penetrates damaged bacterial cells and renders DNA unamplifiable. M. tuberculosis was cultured in broth media containing PMA with or without drugs for 3 days prior to DNA extraction and real-time PCR amplification. 16S rRNA qPCR exhibited a significant decrease in threshold cycle ( C T ) time values ( C T control − C T drug treated) with drug-susceptible strains compared with resistant strains. Susceptibility data were reported as Δ CT or as 2 Δ CT and with appropriate cutoffs yielded an accuracy of 89 to 100% on 38 susceptible, multidrug-resistant, and extensively drug-resistant strains compared with conventional agar proportion susceptibility results for isoniazid, rifampin, ethambutol, streptomycin, amikacin, kanamycin, capreomycin, ofloxacin, moxifloxacin, ethionamide, para -aminosalicylic acid, linezolid, and cycloserine and compared with Bactec MGIT results for pyrazinamide. This PMA-qPCR assay is useful as a rapid 3-day first- and second-line drug susceptibility test for M. tuberculosis .Keywords
This publication has 17 references indexed in Scilit:
- Detection by GenoType MTBDR sl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex IsolatesJournal of Clinical Microbiology, 2010
- An interesting case of rifampicin-dependent/-enhanced multidrug-resistant tuberculosis.2010
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis BacilliChest, 2009
- Performance Assessment of the GenoType MTBDR plus Test and DNA Sequencing in Detection of Multidrug-Resistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2009
- Discrimination of live, anti-tuberculosis agent-injured, and deadMycobacterium tuberculosisusing flow cytometryFEMS Microbiology Letters, 2009
- Importance of the Efflux Pump Systems in the Resistance of Mycobacterium tuberculosis to Fluoroquinolones and LinezolidChemotherapy, 2007
- First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- Detection of Multidrug Resistance in Mycobacterium tuberculosisJournal of Clinical Microbiology, 2007
- Comparison of Two Commercially Available DNA Line Probe Assays for Detection of Multidrug-Resistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2006
- Evaluation of a New Line Probe Assay for Rapid Identification of gyrA Mutations in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2005